Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Neutralase studied in percutaneous coronary intervention trial

May 23, 2000

FDA denies approval for Refludan in acute coronary syndrome

May 19, 2000

Genzyme Transgenics and Genzyme General receive orphan drug designation

May 18, 2000

Eryloside F: a new thrombin receptor antagonist produced by a marine sponge

May 17, 2000

Glaxo Wellcome reveals recent findings in its thrombin inhibitor program

May 17, 2000

Pharmacological profile of SL-650472, a novel antiplatelet, antithrombotic agent

May 15, 2000

Antiplatelet effects of green tea and a major component discussed in Porto

May 12, 2000

New antiplatelet agents with pyrrolidinone structure described by Boehringer Ingelheim

May 12, 2000

Investigational anticoagulant H-376/95/melagatran given wide coverage at recent congress

May 11, 2000

Korean antiplatelet/antithrombotic agent NQ-304 reappears at recent congress

May 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...